Invesco Ltd. Macrogenics Inc Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Macrogenics Inc stock. As of the latest transaction made, Invesco Ltd. holds 34,748 shares of MGNX stock, worth $113,278. This represents 0.0% of its overall portfolio holdings.

Number of Shares

34,748

Previous 35,681 2.61%

Holding current value

$113,278

Previous $151,000 24.5%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$3.0 - $5.55 $2,799 - $5,178	-933 Reduced 2.61%	34,748 $114,000
Q2 2024 Aug 13, 2024	BUY	$3.31 - $18.51 $14,799 - $82,758	4,471 Added 14.33%	35,681 $151,000
Q1 2024 May 14, 2024	SELL	$9.77 - $21.47 $388,523 - $853,797	-39,767 Reduced 56.03%	31,210 $459,000
Q4 2023 Feb 12, 2024	SELL	$4.48 - $10.11 $170 - $384	-38 Reduced 0.05%	70,977 $682,000
Q3 2023 Nov 13, 2023	SELL	$4.48 - $6.19 $1.96 Million - $2.71 Million	-437,909 Reduced 86.05%	71,015 $330,000
Q2 2023 Aug 11, 2023	BUY	$4.62 - $7.54 $726,624 - $1.19 Million	157,278 Added 44.73%	508,924 $2.72 Million
Q1 2023 May 12, 2023	BUY	$4.82 - $7.24 $177,742 - $266,982	36,876 Added 11.72%	351,646 $2.52 Million
Q4 2022 Feb 13, 2023	BUY	$3.34 - $6.98 $847,421 - $1.77 Million	253,719 Added 415.59%	314,770 $2.11 Million
Q3 2022 Nov 14, 2022	SELL	$3.01 - $5.22 $6,989 - $12,120	-2,322 Reduced 3.66%	61,051 $212,000
Q2 2022 Aug 15, 2022	BUY	$2.25 - $9.99 $9,985 - $44,335	4,438 Added 7.53%	63,373 $186,000
Q1 2022 May 16, 2022	BUY	$8.12 - $16.9 $148,604 - $309,286	18,301 Added 45.04%	58,935 $519,000
Q4 2021 Feb 14, 2022	SELL	$15.91 - $21.88 $45,868 - $63,080	-2,883 Reduced 6.62%	40,634 $653,000
Q3 2021 Nov 15, 2021	SELL	$19.74 - $28.7 $174,896 - $254,282	-8,860 Reduced 16.92%	43,517 $911,000
Q2 2021 Aug 17, 2021	BUY	$20.49 - $35.63 $124,866 - $217,129	6,094 Added 13.17%	52,377 $1.41 Million
Q1 2021 May 17, 2021	SELL	$18.99 - $33.2 $56.8 Million - $99.4 Million	-2,992,770 Reduced 98.48%	46,283 $1.47 Million
Q4 2020 Feb 16, 2021	SELL	$19.41 - $26.0 $27.9 Million - $37.3 Million	-1,436,502 Reduced 32.1%	3,039,053 $69.5 Million
Q3 2020 Nov 16, 2020	SELL	$24.69 - $31.6 $65,872 - $84,308	-2,668 Reduced 0.06%	4,475,555 $113 Million
Q2 2020 Aug 14, 2020	SELL	$5.2 - $29.12 $7,009 - $39,253	-1,348 Reduced 0.03%	4,478,223 $125 Million
Q1 2020 May 15, 2020	SELL	$4.28 - $12.11 $82,394 - $233,129	-19,251 Reduced 0.43%	4,479,571 $26.1 Million
Q4 2019 Feb 14, 2020	BUY	$7.95 - $12.27 $83,212 - $128,430	10,467 Added 0.23%	4,498,822 $48.9 Million
Q3 2019 Nov 14, 2019	BUY	$12.44 - $17.48 $28,338 - $39,819	2,278 Added 0.05%	4,488,355 $57.3 Million
Q2 2019 Aug 14, 2019	BUY	$14.51 - $19.71 $64.8 Million - $88.1 Million	4,467,474 Added 24014.8%	4,486,077 $76.1 Million
Q1 2019 May 15, 2019	BUY	$11.11 - $25.6 $21,631 - $49,843	1,947 Added 11.69%	18,603 $334,000
Q4 2018 Feb 14, 2019	BUY	$11.75 - $21.42 $195,708 - $356,771	16,656 New	16,656 $212,000

Others Institutions Holding MGNX

# of Institutions

132

Shares Held

55.4M

Call Options Held

215K

Put Options Held

238K

View Full List

About MACROGENICS INC

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $200M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

More about MGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account